MRC announces health research partnerships between UK and Indian scientists
13 Nov 2015
The UK Medical Research Council has today announced the recipients of two major partnerships with India.
The partnerships will address important challenges facing the two nations – substance misuse and its relationship with mental health, and women’s and children’s health.
The Indian Council for Medical Research - MRC joint initiative: aetiology and life-course of substance misuse and relationship with mental illness will fund collaborative research projects that will study substance misuse and its associated consequences. This is a combined investment of £2.5 million.
The funded projects are:
- Consortium on Vulnerability to Externalizing Disorders and Addictions [c-VEDA] Principal Investigators:
Principal Investigators: Gunter Schumann – King's College London; Vivek Benegal – National Institute of Mental Health & Neuroscience, Bangalore
- Psychosocial and nutritional predictors of child mental health: longitudinal study of shared and distinctive risk and protective factors in UK & India
Principal Investigators: Helen Sharp – University of Liverpool; Prabha Chandra – National Institute of Mental Health & Neuroscience, Bangalore
The Joint Global Research Programme: Women’s and children's health is a partnership between the MRC and the Department of Biotechnology (DBT) in India working in collaboration with the UK Department for International Development, India Office (DFID). This brings together researchers from UK, India and low income countries to address major health needs of women and children in low resource settings. This is a combined investment of £6 million.
The projects supported are:
- Childhood Maltreatment: Emotional Consequences and Potential Intervention Principal Investigators:
Principal Investigators: Jennifer Lau – King's College London; Rakesh Pandey – Banaras Hindu University (BHU), Varanasi; Shanta Niraula – Tribhuvan University, Kathmand
- Epigenetic mechanisms linking maternal pre-conceptional micronutrient supplementation with offspring health in India and The Gambia
Principal Investigators: Caroline Fall – University of Southampton, MRC Lifecourse Epidemiology Unit; Giriraj Chandak – Centre for Cellular & Molecular Biology, Hyderabad; Matt Silver – MRC Unit, The Gambia
- A multicomponent intervention to reduce home-exposure to second-hand smoke (SHS) during pregnancy and postnatal period: a randomised controlled trial
Principal Investigators: Atif Rahman – University of Liverpool; Prabha Chandra – National Institute of Mental Health & Neuroscience, Bangalore; Rumana Huque – ARK Foundation, University of Dhaka
- Ethnic specific risk stratification in early pregnancy for identifying mothers at risk of gestational diabetes mellitus in India and Kenya.
Principal Investigators: Ponnusamy Saravanan – University of Warwick; V Mohan – Madras Diabetes Research Foundation; Sonak Pastakia – Purdue University
- Evaluation of the introduction of a novel device in the management of hypertension and shock in pregnancy in low-resource settings
Principal Investigators: Andrew Shennan – King's College London; Shivaprasad Goudar – KLE University’s Jawaharlal Nehru Medical College; Muchabayiwa Gidiri – University of Zimbabwe
- Impact of maternally derived antibodies and infant microbiota on the immunogenicity of rotavirus vaccines in African, Indian and European infants
Principal Investigators: Miren Iturriza-Gomara – University of Liverpool; Gagandeep Kang – Christian Medical College, Vellore; Queen Dube – University of Malawi
- Impacts of Demand Side financing Instruments on the Continuum of Care for Maternal and Child Health in India and Bangladesh
Principal Investigators: Saseendran Pallikadavath – University of Portsmouth; Udaya S Mishra – Centre for Development Studies, Trivandrum; Abbas Bhuiya – International Centre for Diarrhoeal Disease Research, Bangladesh
Dr Mark Palmer, MRC Director of International Strategy, said: “Bringing together researchers from the UK, India and low income countries gives an exciting opportunity to use the research strengths of each to address some of the biggest health challenges. Over the coming years we hope the outcomes of this work will make a real difference to some of the most vulnerable people.”
The announcement of these major investments follows news of Newton funded UK-India joint centres, awarded earlier this year.
These programmes are funded in part through the Newton-Bhabha Fund - The Newton-Bhabha Fund enables the Research Councils to develop a sustainable long-term partnership with India. For more information visit: www.newtonfund.ac.uk